Pim protein kinase-3 is regulated by TNF-α and promotes endothelial cell sprouting

Amaravadi, R., and Thompson, C.B. (2005). The survival kinases Akt and Pim as potential pharmacological targets. J. Clin. Invest. 115, 2618–2624. Benelli, R., Lorusso, G., Albini, A., and Noonan, D.M. (2006). Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr. Pharm. Des. 12, 3101–3115. Bhattacharya, N., Wang, Z., Davitt, C., McKenzie, I.F., Xing, P.X., and Magnuson, N.S. (2002). Pim-1 associates with protein complexes necessary for mitosis. Chromosoma 111, 80–95. Bochkov, V.N., Philippova, M., Oskolkova, O., Kadl, A., Furnkranz, A., Karabeg, E., Afonyushkin, T., Gruber, F., Breuss, J., Minchenko, A., et al. (2006). Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions. Circ. Res. 99, 900–908. Bradley, J.R. (2008). TNF-mediated inflammatory disease. J. Pathol. 214, 149–160. Carmeliet, P. (2003). Angiogenesis in health and disease. Nat. Med. 9, 653–660. Ezaki, T., Baluk, P., Thurston, G., La Barbara, A., Woo, C., and Mc-Donald, D.M. (2001). Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. Am. J. Pathol. 158, 2043–2055. Fiedler, L.R. (2009). Rac1 regulates cardiovascular development and postnatal function of endothelium. Cell Adh. Migr. 3, 143–145. Frater-Schroder, M., Risau, W., Hallmann, R., Gautschi, P., and Bohlen, P. (1987). Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA 84, 5277–5281. Fujii, C., Nakamoto, Y., Lu, P., Tsuneyama, K., Popivanova, B.K., Kaneko, S., and Mukaida, N. (2005). Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines. Int. J. Cancer 114, 209–218. Gao, B., Saba, T.M., and Tsan, M.F. (2002). Role of alpha(v) beta(3)-integrin in TNF-alpha-induced endothelial cell migration. Am. J. Physiol. 283, C1196–1205. Gavard, J., Lambert, M., Grosheva, I., Marthiens, V., Irinopoulou, T., Riou, J.F., Bershadsky, A., and Mege, R.M. (2004). Lamellipodium extension and cadherin adhesion: two cell responses to cadherin activation relying on distinct signalling pathways. J. Cell Sci. 117, 257–270. Jian, J., Hu, Z.F., and Huang, Y. (2009). Effect of ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic cancer cell line PANC-1. Ai zheng = Aizheng = Chin. J. Cancer 28, 461–465. Kamba, T., and McDonald, D.M. (2007). Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br. J. Cancer 96, 1788–1795. Kociok, N., Radetzky, S., Krohne, T.U., Gavranic, C., and Joussen, A.M. (2006). Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice. Invest. Ophthalmol. Vis. Sci. 47, 5057–5065. Li, Y., Schwabe, R.F., DeVries-Seimon, T., Yao, P.M., Gerbod-Giannone, M.C., Tall, A.R., Davis, R.J., Flavell, R., Brenner, D.A., and Tabas, I. (2005). Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 280, 21763–21772. Li, Y.Y., Popivanova, B.K., Nagai, Y., Ishikura, H., Fujii, C., and Mukaida, N. (2006). Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines. Cancer Res. 66, 6741–6747. Li, Y.Y., Wu, Y., Tsuneyama, K., Baba, T., and Mukaida, N. (2009). Essential contribution of Ets-1 to constitutive Pim-3 expression in human pancreatic cancer cells. Cancer Sci. 100, 396–404. Luo, D., Luo, Y., He, Y., Zhang, H., Zhang, R., Li, X., Dobrucki, W.L., Sinusas, A.J., Sessa, W.C., and Min, W. (2006). Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis. Am. J. Pathol. 169, 1886–1898. Mori, R., Kondo, T., Ohshima, T., Ishida, Y., and Mukaida, N. (2002). Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J. 16, 963–974. Muraski, J.A., Rota, M., Misao, Y., Fransioli, J., Cottage, C., Gude, N., Esposito, G., Delucchi, F., Arcarese, M., Alvarez, R., et al. (2007). Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat. Med. 13, 1467–1475. Numasaki, M., Lotze, M.T., and Sasaki, H. (2004). Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts. Immunol. Lett. 93, 39–43. Pan, S., An, P., Zhang, R., He, X., Yin, G., and Min, W. (2002). Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: role in endothelial cell migration and angiogenesis. Mol. Cell. Biol. 22, 7512–7523. Popivanova, B.K., Li, Y.Y., Zheng, H., Omura, K., Fujii, C., Tsuneyama, K., and Mukaida, N. (2007). Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis. Cancer Sci. 98, 321–328. Secchiero, P., Gonelli, A., Carnevale, E., Corallini, F., Rizzardi, C., Zacchigna, S., Melato, M., and Zauli, G. (2004). Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand. Neoplasia (New York, N.Y) 6, 364–373. Tanner, J.E. (2004). Nucleosomes activate NF-kappaB in endothelial cells for induction of the proangiogenic cytokine IL-8. Int. J. Cancer 112, 155–160. Thurston, G., Murphy, T.J., Baluk, P., Lindsey, J.R., and McDonald, D.M. (1998). Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am. J. Pathol. 153, 1099–1112. Trivella, M., Pezzella, F., Pastorino, U., Harris, A.L., and Altman, D.G. (2007). Microvessel density as a prognostic factor in nonsmall-cell lung carcinoma: a meta-analysis of individual patient data. Lancet Oncol. 8, 488–499. van den Berg, Y.W., van den Hengel, L.G., Myers, H.R., Ayachi, O., Jordanova, E., Ruf, W., Spek, C.A., Reitsma, P.H., Bogdanov, V.Y., and Versteeg, H.H. (2009). Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc. Natl. Acad. Sci. USA 106, 19497–19502. Wingett, D., Reeves, R., and Magnuson, N.S. (1991). Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes. J. Immunol. 147, 3653–3659. Wood, N.T., Meek, D.W., and Mackintosh, C. (2009). 14-3-3 Binding to Pim-phosphorylated Ser166 and Ser186 of human Mdm2—potential interplay with the PKB/Akt pathway and p14(ARF). FEBS Lett. 583, 615–620. Wu, R.F., Xu, Y.C., Ma, Z., Nwariaku, F.E., Sarosi, G.A., Jr., and Terada, L.S. (2005). Subcellular targeting of oxidants during endothelial cell migration. J. Cell Biol. 171, 893–904. Wu, Y., Wang, Y.Y., Nakamoto, Y., Li, Y.Y., Baba, T., Kaneko, S., Fujii, C., and Mukaida, N. (2010). Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver. Oncogene 29, 2228–2237. Yip-Schneider, M.T., Horie, M., and Broxmeyer, H.E. (1995). Transcriptional induction of pim-1 protein kinase gene expression by interferon gamma and posttranscriptional effects on costimulation with steel factor. Blood 85, 3494–3502. Zhang, P., Wang, H., Min, X., Wang, Y., Tang, J., Cheng, J., Li, D., Chen, X., Cheng, F., Wang, N., et al. (2009). Pim-3 is expressed in endothelial cells and promotes vascular tube formation. J. Cell. Physiol. 220, 82–90. Zhu, T., Sennlaub, F., Beauchamp, M.H., Fan, L., Joyal, J.S., Checchin, D., Nim, S., Lachapelle, P., Sirinyan, M., Hou, X., et al. (2006). Proangiogenic effects of protease-activated receptor 2 are tumor necrosis factor-alpha and consecutively Tie2 dependent. Arterioscler. Thromb. Vasc. Biol. 26, 744–750. Zippo, A., De Robertis, A., Bardelli, M., Galvagni, F., and Oliviero, S. (2004). Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 103, 4536–4544.